William Y Kim MD
Genitourinary Oncology, Hematologic Oncology
Professor, Medicine and Genetics, University of North Carolina at Chapel Hill School of Medicine
Join to View Full Profile
101 Manning DrChapel Hill, NC 27514
Phone+1 919-966-4996
Fax+1 919-843-5515
Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1996 - 1999
The Warren Alpert Medical School of Brown UniversityClass of 1996
Certifications & Licensure
NC State Medical License 2006 - 2025
MA State Medical License 1999 - 2006
Clinical Trials
- Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer Start of enrollment: 2009 May 01
- Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy Start of enrollment: 2012 Jun 01
- Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- 17 citationsAdjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.Andrea B Apolo, Karla V Ballman, Guru Sonpavde, Stephanie Berg, William Y Kim
The New England Journal of Medicine. 2025-01-02 - 3 citationsCAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms.Xin Zhou, Ying Wang, Zhangqi Dou, Gloria Delfanti, Ourania Tsahouridis
Nature Cancer. 2024-11-01 - Renal Cell Carcinoma: A Review.Tracy L Rose, William Y Kim
JAMA. 2024-09-24
Journal Articles
- VHL Substrate Transcription Factor ZHX2 as an Oncogenic Driver in Clear Cell Renal Cell CarcinomaEric Jonasch, Xian Chen, William Y Kim, W Kimryn Rathmell, Science Magazine
Press Mentions
Review Highlights Advances in Kidney Cancer Research and CareAugust 28th, 2024- Newsworthy from the School of Medicine, Week of August 12 – 19August 18th, 2021
GeneCentric Therapeutics to Present New Analyses of Molecular Characterization and Prediction of Treatment Response in Patients with Muscle Invasive Bladder Cancer (MIBC)February 13th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
